- Home
- EIC vs SOPH Comparison
EIC vs SOPH Comparison
Compare EIC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EIC
- SOPH
- Stock Information
- Founded
- EIC N/A
- SOPH 2011
- Country
- EIC United States
- SOPH Switzerland
- Employees
- EIC N/A
- SOPH N/A
- Industry
- EIC Finance/Investors Services
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EIC Finance
- SOPH Health Care
- Exchange
- EIC Nasdaq
- SOPH Nasdaq
- Market Cap
- EIC 341.0M
- SOPH 193.8M
- IPO Year
- EIC 2019
- SOPH 2021
- Fundamental
- Price
- EIC $13.74
- SOPH $3.04
- Analyst Decision
- EIC Strong Buy
- SOPH Buy
- Analyst Count
- EIC 1
- SOPH 1
- Target Price
- EIC $17.50
- SOPH $7.00
- AVG Volume (30 Days)
- EIC 291.4K
- SOPH 169.5K
- Earning Date
- EIC 08-05-2025
- SOPH 08-05-2025
- Dividend Yield
- EIC 17.47%
- SOPH N/A
- EPS Growth
- EIC N/A
- SOPH N/A
- EPS
- EIC 0.55
- SOPH N/A
- Revenue
- EIC $51,224,692.00
- SOPH $67,173,000.00
- Revenue This Year
- EIC $42.67
- SOPH $16.07
- Revenue Next Year
- EIC $29.16
- SOPH $22.94
- P/E Ratio
- EIC $24.91
- SOPH N/A
- Revenue Growth
- EIC 68.61
- SOPH 4.66
- 52 Week Low
- EIC $12.63
- SOPH $2.58
- 52 Week High
- EIC $16.71
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- EIC 56.13
- SOPH 49.93
- Support Level
- EIC $13.32
- SOPH $2.99
- Resistance Level
- EIC $13.83
- SOPH $3.25
- Average True Range (ATR)
- EIC 0.19
- SOPH 0.25
- MACD
- EIC 0.09
- SOPH 0.02
- Stochastic Oscillator
- EIC 86.36
- SOPH 55.29
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.